Advanced Biomed Inc.

ADVB Healthcare Diagnostics & Research

Advanced Biomed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $127,600.00. In the quarter to June 2026, EPS grew 54.8% and free cash flow fell 101.3%, each against the same quarter a year earlier.

3.98 0.90 −18.44%
Market cap
$8.1M
P/E
0.8×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
0.68
Beneish M
n/a
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jun '24 Jun '25 Jun '26
Net Income
(2.78) (3.26) 6.68
Operating Cash Flow
(2.13) (5.83) (1.95)
Investing cash flow
(0.07) (0.03) (2.51)
Financing cash flow
1.87 5.93 1.97
Ending Cash
2.61 2.90 0.39
Other line items

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 15 Oct 2026